In the Netherlands and Germany, the necessary outpatient excision of CSCC drove the higher costs for that treatment, while febrile/afebrile neutropenia expenditure was related to use of granulocyte colony-stimulating factors (GCSF). Here, CSF3 is linked to neutropenia.